Liu, Yanxin, et al. “Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 25, Dec. 2022, pp. 377-90, doi:10.18433/jpps33020.